LOPERAMIDE HYDROCHL

The Defense Logistics Agency awarded a single-line-item contract to DMS PHARMACEUTICAL GROUP INC under solicitation SPE2DP26F7540 for the delivery of one pound gross of Loperamide Hydrochloride, identified by NSN 6505015495732, at a total contract value of $0.80. The award, issued on July 14, 2026, is executed under delivery order SPE2DX25D9900 and requires shipment to Fort Hood, Texas, with delivery due by July 29, 2026. FOB destination terms apply, and the contractor is responsible for all shipping, inspection, and acceptance logistics, with shipments required to be sent via traceable means and strictly prohibited from using parcel post. Each package must be marked with the designated Mark For identifier W80XYJ, Military Freight identifier W80XYJ61660229, NSN, and associated CAGE codes 9DDF3 and 1LEZO. The contract contains no specified clauses, representations, certifications, or evaluation factors typical in larger procurements; no FAR/DFARS clauses, attachment lists, appraisal data, or point of contact information are included. The procurement appears to follow a streamlined, low-value transaction model with no quantity variance allowed and no options or extensions. Pharmaceutical compliance is implied through the use of NSN and medical substitution references, but no explicit regulatory standards or quality specifications are cited. Funding details such as AAC, TAS, or ACRN are absent, though DIC, DIST, ADV, and FC codes are provided for internal tracking, alongside the Purchase Request number 7017497061. Invoicing methods and payment office details are not specified, and no COR, COTR, or PCO information is listed. The contract reflects a minimalistic, high-efficiency logistics transaction typical of bulk pharmaceutical replenishment under DLA’s supply chain operations.